Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

LEO Pharma ItaliaLEO Pharma Italia
VS
MENARINI GroupMENARINI Group
LEO Pharma Italia

LEO Pharma Italia

Via Elio Vittorini, 129, Roma, 00144, IT

Last Update: 09/06/2026

View Profile
Between 750 and 799
http://www.leo-pharma.it
757/1000Fair

LEO Pharma è un’azienda farmaceutica danese, fondata nel 1908, leader a livello mondiale nella cura delle patologie dermatologiche. LEO Pharma vanta una presenza in più di 60 Paesi e commercializza i suoi prodotti in oltre 130 mercati. L’azienda ha dedicato decenni all...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:None
Subsidiaries:5
12-month incidents
0
Known data breaches
0
Attack type number
0
MENARINI Group

MENARINI Group

Via dei Sette Santi 1/3, Firenze, 50131, IT

Last Update: 02/04/2026

View Profile
Between 750 and 799
https://www.menarini.com
784/1000Fair

The Menarini Group is a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide, with a turnover of 4,37 Billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in ...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:12,720
Subsidiaries:0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
LEO Pharma Italia

LEO Pharma Italia

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
MENARINI Group

MENARINI Group

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for LEO Pharma Italia in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MENARINI Group in 2026.

Incidents

Incident History - LEO Pharma Italia (X = Date, Y = Severity)

LEO Pharma Italia cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - MENARINI Group (X = Date, Y = Severity)

MENARINI Group cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
LEO Pharma Italia

LEO Pharma Italia

Incidents
No explicit notable incidents reported.
MENARINI Group

MENARINI Group

Incidents
No explicit notable incidents reported.

FAQ

Between LEO Pharma Italia company and MENARINI Group company, which one has the best AI Cybersecurity Score ?
Between LEO Pharma Italia company and MENARINI Group company, which one has experienced more cyber incidents in the past ?
Between LEO Pharma Italia company and MENARINI Group company, which one has experienced more cyber incidents this year ?
Between LEO Pharma Italia company and MENARINI Group company, which one has experienced at least one ransomware attack ?
Between LEO Pharma Italia company and MENARINI Group company, which one has experienced at least one data breach ?
Between LEO Pharma Italia company and MENARINI Group company, which one has experienced at least one targeted cyberattack ?
Between LEO Pharma Italia company and MENARINI Group company, which one has experienced at least one vulnerability ?
Between LEO Pharma Italia company and MENARINI Group company, which one holds the most compliance certifications ?
Between LEO Pharma Italia company and MENARINI Group company, which one holds the fewest compliance certifications ?
Between LEO Pharma Italia company and MENARINI Group company, which one has the most subsidiaries ?
Between LEO Pharma Italia company and MENARINI Group company, which one has the largest number of employees ?
Between LEO Pharma Italia and MENARINI Group, which company holds both SOC 2 Type 1 certifications ?
Between LEO Pharma Italia and MENARINI Group, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - LEO Pharma Italia or MENARINI Group ?
Which company is PCI DSS compliant - LEO Pharma Italia or MENARINI Group ?
Between LEO Pharma Italia and MENARINI Group, which company complies with HIPAA regulations for healthcare data ?
Between LEO Pharma Italia and MENARINI Group, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-19961
SUMMARY

A vulnerability was detected in Edimax EW-7478APC 1.04. Affected is the function formWlSiteSurvey of the file /goform/formWlSiteSurvey. Performing a manipulation of the argument selSSID results in buffer overflow. The attack is possible to be carried out remotely. The exploit is now public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-08-16
UPDATED
Date2026-08-16
RISK INFORMATION (Score: 9.9)
CVSS2
Base Score: 9.0
Complexity: LOW
AV:N/AC:L/Au:S/C:C/I:C/A:C
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 8.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
3.1
CVE-2026-19960
SUMMARY

A security vulnerability has been detected in Edimax EW-7478APC 1.04. This impacts the function formWlbasic of the file /goform/formWlbasic. Such manipulation of the argument rootAPmac leads to command injection. The attack can be executed remotely. The exploit has been disclosed publicly and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-08-16
UPDATED
Date2026-08-16
RISK INFORMATION (Score: 7.4)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 7.4
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:L/SI:L/SA:L/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.7
EXPLOITABILITY
3.1
CVE-2026-19959
SUMMARY

A weakness has been identified in Edimax EW-7478APC 1.04. This affects the function formWanTcpipSetup of the file /goform/formWanTcpipSetup. This manipulation of the argument pppUserName causes stack-based buffer overflow. Remote exploitation of the attack is possible. The exploit has been made available to the public and could be used for attacks. The vendor was contacted early about this disclosure but did not respond in any way.

PUBLISHED
Date2026-08-16
UPDATED
Date2026-08-16
RISK INFORMATION (Score: 9.9)
CVSS2
Base Score: 9.0
Complexity: LOW
AV:N/AC:L/Au:S/C:C/I:C/A:C
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
CVSS4
Base Score: 8.6
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
6
EXPLOITABILITY
3.1
CVE-2026-19958
SUMMARY

A security flaw has been discovered in iatsiuk pptr-mcp up to 0.2.7. The impacted element is the function executeCode of the file src/vm-executor.ts of the component execute Tool. The manipulation results in code injection. The attack may be launched remotely. The exploit has been released to the public and may be used for attacks. The project was informed of the problem early through an issue report but has not responded yet.

PUBLISHED
Date2026-08-16
UPDATED
Date2026-08-16
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8
CVE-2026-19957
SUMMARY

A vulnerability was identified in graphlit graphlit-mcp-server 1.0.1. This affects the function fetch of the file src/tools.ts of the component ssrf-test Endpoint. Such manipulation of the argument url leads to server-side request forgery. The attack may be launched remotely. The exploit is publicly available and might be used. The project was informed of the problem early through an issue report but has not responded yet.

PUBLISHED
Date2026-08-16
UPDATED
Date2026-08-16
RISK INFORMATION (Score: 6.3)
CVSS2
Base Score: 6.5
Complexity: LOW
AV:N/AC:L/Au:S/C:P/I:P/A:P
CVSS3
Base Score: 6.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L
CVSS4
Base Score: 2.1
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.4
EXPLOITABILITY
2.8